BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia - Chong, Stephen Jun Fei; Lu, Junyan; Valentin, Rebecca; Lehmberg, Timothy Z.; Eu, Jie Qing; Wang, Jing; Zhu, Fen; Kong, Li Ren; Fernandes, Stacey M.; Zhang, Jeremy; Herbaux, Charles; Goh, Boon Cher; et al. (Molecular cancer, 2025)
Gesehen am 31.07.2025